Study Evaluating the Equivalence of GDC-229 and Metronidazole Vaginal Gel 0.75% in the Treatment of Bacterial Vaginosis
Status:
Completed
Trial end date:
2018-03-27
Target enrollment:
Participant gender:
Summary
This research study is being done to compare the safety and efficacy of GDC-229 (test drug)
against the currently marketed reference drug (metronidazole 0.75% vaginal gel) and to
establish that these two drugs work better than placebo in subjects with BV.